Sing Medical – Trades at a 13-month low price despite posting record 1HFY21 results (3 Feb 22)

Dear all On 29 Dec 2020, I have published a write-up on Sing Medical (“SMG”) where I outlined that the risk reward on SMG seems favourable at $0.315, given a potential share transaction scenario (click HERE). Since 29 Dec, SMG rose approximately 32% to trade $0.415 – 0.420 on several occasions in Feb 2021. Subsequently, it dropped sharply in Apr 2021 when it announced that the potential share transaction has lapsed. Fast forward to 31 Jan 2022 and SMG closed at a 13-month low at $0.290. This is notwithstanding its sterling record 1HFY21 results announced in Aug last year where […]

Navigating Depressions and Great Recessions (Real Estate Edition, 8 May 20)

This write-up was reproduced with permission from Ray’s Estate Clinic, written by Founder, Raymond Chng. Please refer to the end of the article for more information on Raymond. We are currently in unprecedented times (as of writing in April 2020). Covid-19 is upon us as a global pandemic which will go down in history books as the gravest health crisis mankind ever faced in this century. Over the past few weeks, I had the fortune to converse and interview numerous Seniors (our Merdeka & Pioneer Generation) whom I knew for some time already. The wiser generation I interviewed range from […]

Ernest’s market opinion (19 May 17)

Dear all Below is my personal opinion on the market. As previously mentioned to my clients, I aim to reduce my percentage invested in stocks (currently around 130% invested), especially the non-performing stocks, with no immediate near term catalysts. I am cautious on the market in the next 1-2 months because a) The large market run up year to date. STI has appreciated approximately 12% YTD and 22% for the past one year; b) June is likely to be a quiet month as most companies have reported results and some of the blue chips have already ex dividend. i.e. limited […]